Therachon None

Therachon is a biotech company that develops treatments for rare genetic diseases. Its lead candidate, TA-46, is a protein therapy being developed for achondroplasia. The company is based in Basel, Switzerland, with research labs in Nice, France. The text also mentions a topic unrelated to Therachon, which is the comparison between biologics and biosimilars in terms of cost.